Geneos Therapeutics Company
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Industry:
DNA
Investors Number:
5
Last Funding Type:
Series A
Total Funding:
39500000
Funding Status:
Early Stage Venture
Headquarters:
Plymouth Meeting, Pennsylvania, United States
Founded Date:
2016-08-01
Employee Number:
1-10
Last Funding Date:
2022-03-24
Estimated Revenue:
$1M to $10M